期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

信号转导通路在非霍奇金淋巴瘤中的作用研究进展 被引量：5

Roles of Signal Transduction Pathway in Non-Hodgkin′s Lymphoma——Review
下载PDF
导出
摘要 信号通路(signal pathway)的研究已逐渐发展成为生命科学科研领域的热点和重点。愈来愈多的证据表明,信号通路与多种肿瘤的发生、发展、预后及耐药密切相关,在非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)中也具有显著的相关性。阐明信号传导通路的生物学功能及其与NHL的关系,选择性地调控该生物学活性可能为NHL的治疗提供一个新的途径。为进一步了解信号转导在NHL发病机制及发生、发展、治疗及预后中的影响,本文将根据近年来NHL病例的相关报道,结合信号通路诸如核转录因子κB信号通路、PI3K信号通路、Notch信号通路、Hh信号通路、MAPK信号通路、JAK-STAT信号通路、Wnt信号通路、cAMP信号通路等进行系统性综述。 The study of signal pathway has become a hotspot and a key in life science.In recent years,it has been found that many signaling pathways are associated with the occurrence,development,prognosis and drug resistance of many malignancies,including non-Hodgkin′s lymphoma（NHL）.Understanding the biological function of the signaling pathway and its relation with NHL,selectively controling its biological activities may provide a new way for the treatment of NHL.In order to further investigate the function of signal pathways in pathogenesis,development and treatment of NHL,this review summarizes briefly the advances in the signal pathways related with the NHL including NF-κB,PI3K-AKT,Notch,Hh,MAPK,JAK-STAT,Wnt and cAMP.
作者 张希远 王欣
机构地区 山东大学附属省立医院血液科
出处 《中国实验血液学杂志》 CAS CSCD 2011年第2期532-536,共5页 Journal of Experimental Hematology
基金 山东省科技发展计划项目(编号2007GG10002008) 山东省自然科学基金(编号Y2007C053) (编号ZR2009CM059)
关键词 淋巴瘤 信号通路 非霍奇金淋巴瘤 lymphoma non-Hodgkins lymphoma signal pathway
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献36

  • 1Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol, 2004 ; 25 (6) : 280 - 288.
  • 2Jost PP, Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood, 2007 ; 109(7) : 2700 -2707.
  • 3Hosokawa Y, Suzuki H, Nakagawa M, et al. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-2kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation. Biochem Biophys Res Commun, 2005 ; 334( 1 ) : 51 -60.
  • 4Davis RE, Brown KD, et al. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med, 2001 ; 194 : 1861 - 1874.
  • 5Bemal-Mizrachi L, Lovly CM, Rather L. The role of NF- ( kappa ) B-1 and NF-( kappa ) B-2-mediated resistance to apoptosis in lymphomas. Proc Nail Acad Sci USA, 2006 ; 103 ( 24 ) : 9220 - 9225.
  • 6Jazilehi AR, Huerta-Yepez S, Cheng G, et al. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-( kappa ) B signaling pathway in non-Hodgkin' s lymphoma B-ceU lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res, 2005 ; 65 ( 1 ) : 264 - 276.
  • 7Uddin S, Hussain AR, Siraj AK, et al. Role of phosphatidy- linositol 3 '-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood, 2006; 108(13) : 4178 -4186.
  • 8Smith PG, Wang F, Wilkinson KN, et al. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood, 2005 ; 105 ( 1 ) : 308 - 316.
  • 9Georgakis GV, Younes A. From Rapa Nui to rapamycin: targeting PI3 K/Akt/mTOR for cancer therapy. Expert Rev Anticancer Ther, 2006; 6(1) :131 -140.
  • 10Argyriou P, Papageorgiou SG, Pantcleon V, et al. Hypoxia- inducible factors in mantle cell lymphoma: implication for an activated mTORC1 → HIF-1α pathway. Ann Hematol, 2010; [Epub ahead of print ].

二级参考文献54

  • 1Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 2004 ;303 (5663) : 1483 - 1487.
  • 2Li F, Chong ZZ, Maiese K. Vital elements of the Wnt-Frizzled signalling pathway in the nervous system. Curt Neurovasc Res, 2005 ;2:331 - 340.
  • 3Cong F,Schweizer L,Varmus H. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development, 2004; 131:5103 -5115.
  • 4Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-induced changes in GSK3 beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol, 2005 ;15:1989 - 1997.
  • 5Liu F, van-den Broek O, Destree O, et al. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/ beta-catenin signalling in mesoderm development. Development, 2005 ; 132:5375 - 5385.
  • 6Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci,2006 ; 119 ( Pt 3 ) :395 -402.
  • 7Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm :Wnt signalling in cancer. Biochim Biophys Acta, 2003;1653:1 -24.
  • 8Seto ES, Bellen HJ. The ins and outs of Wingless signalling. Trends Cell Biol, 2004 ; 14:45 - 53.
  • 9Derksen PW, Tjin E, Meijer HP, et al. Illegitimate WNT signalling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA, 2004 ; 101:6122 - 6127.
  • 10Chim CS, Pang R, Fung TK, et al. Epigenetic dysregulation of Writ signalling pathway in multiple myeloma. Leukemia, 2007 ;21 : 2527 - 2536.

共引文献8

同被引文献62

引证文献5

二级引证文献27

中国实验血液学杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部